ArticlePathogens & immunity2019

Four Weeks of Treatment With Rifaximin Fails to Significantly Alter Microbial Diversity in Rectal Samples of HIV-Infected Immune Non-Responders (ACTG A5286) Which May be Attributed to Rectal Swab Use.

Brett B Williams et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.